<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>HIV and Skin</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>

    <h1>HIV and Skin</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
          <div class="custom-card" id="custom-card-1">
            <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
            <div class="title"> 
              <h2>What You Will Learn</h2>
            </div>
            <div class="line">
              <p>After reading this note, you should be able to...</p>
            </div>
            <div class="content">
              <ul>
                <li><i>This content is not available yet.</i></li>
            </ul>
            </div>
            <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
          </div>
        
      <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
    
    
      <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
        <div class="outline2">
    
          <input type="radio" name="control-2" id="show-2">
          <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
          <input type="radio" name="control-2" id="hide-2">
          <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
          <div class="contents">
            <div class="icon-box">
              <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
              <img src="../images/icons/book.png" alt="Icon" class="icon">
            </div>
            <div id="tableOfContents">
                <ol id="tocList"></ol>
            </div>
          </div>
         <div>
    
    <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
    
    
    <!-- READ SUMMARY CONTAINER -->
    
          <!-- Summary Overlay -->
          <div class="summary-overlay" id="summaryOverlay"></div>
    
    
          <div class="summary-card" id="summaryCard">
            
            <div class="summary-header">
              <h3>Note Summary</h3>
              <div class="icon-box">
                <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                <img src="../images/icons/summary.png" alt="Icon" class="icon">
              </div>
            </div>
            <div class="summary-content">
              <!-- Summary content goes here -->
              <p><i>This content is not available yet.</i></p>
    
              <span class="close-btn" id="closeBtn">close</span>
            </div>
          </div>
    
          <div class="summary-trigger" id="summaryTrigger">
            <p>Click here to read a summary</p>
        </div>
    <!-- END OF READ SUMMARY CONTAINER -->

      <br>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <p>The skin is the interface between humans and their environment.</p>
            <p>It is the largest organ in the body. It weighs an average of 4 kg and covers an area of 2 m<sup>2</sup>.</p>
            <p>It acts as a barrier, protecting the body from harsh external conditions and preventing the loss of important body constituents, especially water.</p>
            <p>The skin has two layers.</p>
            <ul>
                <li>The outer is epithelial, the epidermis, which is firmly attached to, and supported by connective tissue in the underlying dermis. In between the epidermis and the dermis is the basement membrane.</li>
                <li>The downward progression of the epidermis to the dermis is the rete pegs/ridges while the upwards attachment of the dermis to epidermis is dermal papillae. Beneath the dermis is loose connective tissue, the subcutis/hypodermis which usually contains abundant fat.</li>
            </ul>
            
            <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (0).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Embryology of the Skin</a>
          </h2>
        </header>
        <div class='body'>
          <h4>Skin Development</h4>
          <ul>
              <li>The skin has dual origin:</li>
              <li>A superficial layer, the <strong>epidermis</strong>, which develops from surface ectoderm.</li>
              <li>A deep layer, the <strong>dermis</strong>, which develops from the underlying mesenchyme.</li>
              <li>The embryo is covered initially by a single layer of ectodermal cells.</li>
              <li>The epithelium starts to divide in the second month, forming different layers over time.</li>
              <li>At the end of the fourth month, four distinct layers can be distinguished.</li>
          </ul>
      
          <h4>Epidermal Layers</h4>
          <ul>
              <li>The <strong>basal layer</strong> produces new cells.</li>
              <li>The <strong>spinous layer</strong> consists of large polyhedral cells containing fine tonofibrils.</li>
              <li>The <strong>granular layer</strong> contains small keratohyalin granules in its cells.</li>
              <li>The <strong>horny layer</strong> forms the tough scale-like surface of the epidermis and is made up of dead cells containing keratin.</li>
              <li>Cells of the periderm are usually shed during the second part of intrauterine life and can be found in amniotic fluid.</li>
          </ul>
      
          <h4>Pigmentation</h4>
          <ul>
              <li>During the first three months, the epidermis is invaded by cells arising from neural crest.</li>
              <li>These cells synthesize <strong>melanin pigment</strong> and transmit it to other epidermal cells through dendritic processes.</li>
          </ul>
      
          <h4>Dermis Development</h4>
          <ul>
              <li>The dermis is derived from lateral plate mesoderm and dermatomes from somites.</li>
              <li>During the third and fourth months, the corium forms many irregular papillary structures, the <strong>dermal papillae</strong>.</li>
              <li>At birth, the skin is covered by a whitish plate called <strong>vernix caseosa</strong>, formed by secretions from sebaceous glands and degenerated epidermal cells and hair. This protects the skin against the macerating action of amniotic fluid.</li>
          </ul>
      
          <h4>Hair Development</h4>
          <ul>
              <li>Hair appears as a solid epidermal proliferation penetrating the underlying dermis.</li>
              <li>Hair buds invaginate at their terminal ends, forming <strong>hair papillae</strong>, which are filled with mesoderm, vessels, and nerve endings.</li>
              <li>Cells in the center of the hair buds become spindle-shaped and keratinized, forming the <strong>hair shaft</strong>.</li>
              <li>Hair follicles follow a growth cycle: <strong>anagen</strong> (growth phase), <strong>catagen</strong> (involution phase), and <strong>telogen</strong> (shedding phase).</li>
              <li>Most hairs are in the <strong>anagen phase</strong> at any given time (three to five years for scalp hair).</li>
              <li><strong>Grey hair</strong> results from decreased tyrosinase activity in hair bulb melanocytes, while <strong>white hair</strong> is due to the total loss of these melanocytes.</li>
          </ul>
        
                    <!-- image here -->
    <div class="image-container">
        <img src="../figures/hiv-skin (1).png" alt="" onclick="openModal(this)">
        <div class="caption">Stages of hair development</div>
      </div>
      
      <div id="myModal" class="modal">
        <span class="close" onclick="closeModal()">&times;</span>
        <img class="modal-content" id="modalImage">
        <div id="caption" class="caption">Stages of hair development</div>
      </div>

      <p>Nails are tough plates of hardened keratin which arise from the nail matrix, just visible as the moon-shaped lunula under the nail fold. It takes six months for a fingernail to grow out fully and one year for a toenail.</p>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Structure and Functions of the Skin</a>
          </h2>
        </header>
        <div class='body'>
            <h4>The Epidermis</h4>
            
            <p>The epidermis is a stratified epithelium that arises from dividing basal keratinocytes, and the projection of the epidermis into the dermis forms rete ridges.</p>
            
                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/hiv-skin (1).jpg" alt="" onclick="openModal(this)">
                            <div class="caption">The struucture of the skin</div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">The struucture of the skin</div>
                          </div>
            <p>The basal layer produces a variety of keratin filaments and desmosomal proteins, such as desmoglein and desmoplakin, which make up the cytoskeleton. This confers strength to the epidermis and prevents it from shedding off.</p>
            
            <p>Higher up in the granular layer, complex lipids are secreted by keratinocytes, and this forms the intracellular lipid bilayer, which acts as a semipermeable skin barrier.</p>
            
            <p>The upper cells, the stratum corneum, lose their nuclei and become surrounded by a tough impermeable envelope of various proteins, including loricrin, involucrin, filaggrin, and keratin.</p>

                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/hiv-skin (2).png" alt="" onclick="openModal(this)">
                            <div class="caption">Changes during keratinization</div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">Changes during keratinization</div>
                          </div>

                                      <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (3).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (2).jpg" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (4).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
            
              <p><strong>Keratinocytes</strong> can secrete a variety of cytokines, interleukins, and gamma interferon. They play a role in specific immune function, cutaneous inflammation, and tissue repair. There is also an innate immune system in the skin, which includes neutrophils and macrophages, as well as antimicrobial peptides produced by keratinocytes called Œ≤-defensins and cathelicidins. These peptides are active against bacterial, viral, and fungal pathogens.</p>

              <p><strong>Other cells in the epidermis:</strong></p>
              
              <ul>
                <li><strong>Melanocytes:</strong> Found in the basal layer, melanocytes secrete the pigment melanin, which protects against ultraviolet radiation. Racial differences in skin color are due to variation in melanin production and not melanocyte numbers.</li>
                <li><strong>Merkel cells:</strong> Also found in the basal layer, Merkel cells are numerous on fingertips and in the oral cavity, and they play a role in sensation.</li>
                <li><strong>Langerhans cells:</strong> These dendritic cells are found in the suprabasal layer and act as antigen-presenting cells.</li>
              </ul>
              

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (5).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <p><strong>Basement Membrane Zone</strong></p>

              <p>This is a complex proteinaceous structure consisting of type 4, type 7, and type 17 (BP 180) collagen, hemidesmosomal protein, integrin, and laminin. Collectively, they hold the skin together, keeping the epidermis firmly attached to the dermis.</p>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (6).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <p><strong>Dermis</strong></p>

              <p>The dermis is mesodermal in origin and contains blood and lymphatic vessels, nerves, muscles, appendages such as sweat glands, sebaceous glands, and hair follicles. It also contains a variety of immune cells such as mast cells and lymphocytes. It is a matrix of collagen and elastin in a ground substance.</p>
              

            <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (7).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
            
              <p><strong>Sweat Glands</strong></p>

              <p>Eccrine sweat glands are found throughout the skin except on mucosal surfaces.</p>
              
              <p>Apocrine sweat glands are found in axillae, anogenital areas, and the scalp and do not function until puberty.</p>
              
              <p>The sweat glands and vasculature are involved in temperature control.</p>
              
              <p><strong>Sebaceous Glands</strong></p>
              
              <p>Sebaceous glands are inactive until puberty. They are responsible for secreting sebum or grease onto the skin surface through the hair follicle and are found in high numbers on the face and scalp.</p>
              
              <p><strong>Nerves</strong></p>
              
              <p>The skin is richly innervated. These fibers allow sensation of touch, pain, itch, vibration, and changes in temperature.</p>
              
              <p><strong>Hair</strong></p>
              
              <p>Hair arises from a downgrowth of epidermal keratinocytes into the dermis.</p>
              
              <p>The hair shaft has an inner and outer root sheath, a cortex, and sometimes a medulla. The lower portion of the hair follicle consists of an expanded bulb that also contains melanocytes surrounding a richly innervated and vascularized dermal papilla. The hair regrows from the bulb after shedding.</p>
              
              <p>There are three types of hair:</p>
              
              <ul>
                <li>Terminal: medullated coarse hair, e.g., scalp, beard, and pubic hair.</li>
                <li>Vellus: non-medullated fine downy hair seen on the face of women and in prepubertal children.</li>
                <li>Lanugo: non-medullated soft hair on newborns, most marked in premature babies and occasionally in people with anorexia nervosa.</li>
              </ul>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (8).png" alt="" onclick="openModal(this)">
                <div class="caption"> </div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Hair structure</div> 
              </div>
              

              <p><strong>Nails</strong></p>

              <p>Nails are tough plates of hardened keratin that arise from the matrix of a nail fold.</p>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hiv-skin (9).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <p><strong>Subcutaneous layer</strong></p>

              <p>The subcutaneous layer consists predominantly of adipose tissue as well as blood vessels and nerves. This layer provides insulation and acts as a lipid store.</p>
              
              
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>HIV and AIDS</a>
          </h2>
        </header>
        <div class='body'>

          <section id='heading-4-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-1'>Types of HIV</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>HIV-1 and HIV-2 are types of HIV.</li>
                <li>Both types are transmitted the same way.</li>
                <li>Both are associated with similar opportunistic infections and AIDS.</li>
                <li>HIV-1 is more common worldwide.</li>
                <li>HIV-2 is found predominantly in West Africa, Angola, and Mozambique.</li>
              </ul>
              
              <p><strong>Differences between HIV-1 and HIV-2</strong></p>
              
              <ul>
                <li>HIV-2 is less easily transmitted than is HIV-1.</li>
                <li>HIV-2 is less pathogenic, meaning that the period between initial infection and illness is longer.</li>
                <li>While HIV-2 can be transmitted from an infected mother to her child, this appears to be rare (0% to 5% transmission rate in breastfed infants in the absence of any interventions).</li>
              </ul>
              
              <p><strong>Global Estimates for Adults and Children</strong></p>
              
              <ul>
                <li>People living with HIV: 39.5 million (34.1‚Äì47.1 million)</li>
                <li>New HIV infections in 2006: 4.3 million (3.6‚Äì6.6 million)</li>
                <li>Deaths due to AIDS in 2006: 2.9 million (2.5‚Äì3.5 million)</li>
              </ul>
              


                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (10).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>

                                    <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (11).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <p><strong>Composition</strong></p>

            <ul>
              <li><strong>3 viral enzymes</strong></li>
              <li>1. Reverse transcriptase - Converts viral RNA into DNA.</li>
              <li>2. Integrase - Incorporates viral DNA into host cell chromosomes (provirus).</li>
              <li>3. Protease - Cleaves precursor protein GP160 into GP 120 and GP 41 so that new viruses can be assembled.</li>
            </ul>
            
            <ul>
              <li><strong>3 genes</strong></li>
              <li>1. Gag - gp 55 - p24 and p18</li>
              <li>2. Pol ‚Äì Reverse transcriptase and integrase</li>
              <li>3. Env - 160 - gp120 and 14</li>
            </ul>
            
                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (12).png" alt="" onclick="openModal(this)">
                          <div class="caption">Structure of the HIV virion</div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption">Structure of the HIV virion</div>
                        </div>

            </div>
          </section>

          <section id='heading-4-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-2'>Transmission</a>
              </h3>
            </header>
            <div class='body'>

              <p><strong>How is HIV transmitted?</strong></p>
              
              <ul>
                <li>Sex</li>
                <li>Heterosexual (M to F, F to M)</li>
                <li>Homosexual (male to male, female to female)</li>
                <li>Bisexual</li>
                <li>Parenteral</li>
                <li>Mother to child.</li>
                <li>"Unknown"</li>
              </ul>
              
              <p><strong>Sexual contact</strong></p>
              
              <ul>
                <li>Unprotected sexual intercourse (vaginal, oral, or anal)</li>
                <li>Heterosexual transmission is the primary mode of acquiring HIV in developing countries.</li>
                <li>Direct contact with HIV-infected body fluids such as semen and cervical and vaginal secretions</li>
                <li>Women, especially young girls, are more likely than men to become infected following heterosexual intercourse due to biological, socio-economic and cultural reasons.</li>
                <li>Cases of HIV infection resulting from sexual abuse of children, and even infants, have been reported.</li>
                <li>Role of STIs</li>
              </ul>

              <table class="note-table">
                <tr>
                  <th>Sex Act</th>
                  <th>Estimated Risk of Acquiring HIV Infection Per Contact (%)</th>
                </tr>
                <tr>
                  <td>Female to male vaginal sex</td>
                  <td>0.0003-0.0014%</td>
                </tr>
                <tr>
                  <td>Male to female vaginal sex</td>
                  <td>2.3-20 x above</td>
                </tr>
                <tr>
                  <td>Receptive anal sex</td>
                  <td>0.82</td>
                </tr>
                <tr>
                  <td>Insertive anal sex</td>
                  <td>0.06</td>
                </tr>
                <tr>
                  <td>Receptive fellatio</td>
                  <td>0.04</td>
                </tr>
                <caption>Estimates of HIV transmission risk per contact</caption>
              </table>
              
              
              <p><strong>Parenteral</strong></p>

              <ul>
                <li>Injection drug use</li>
                <ul>
                  <li>Injection of drugs with needles or syringes contaminated with HIV</li>
                </ul>
                <li>Blood-to-blood transmission</li>
                <ul>
                  <li>Transfusion with HIV-infected blood/blood products</li>
                  <li>Direct contact with HIV-infected blood</li>
                  <li>Needlestick injuries</li>
                </ul>
                <li>Traditional Practices</li>
                <ul>
                  <li>Group circumcision</li>
                  <li>Tattoos/scarification</li>
                  <li>Barbing</li>
                  <li>Nail cutting</li>
                  <li>Cupping, etc.</li>
                </ul>
              </ul>
              
              <p><em>Not aware of studies that confirmed these.</em></p>

              <p><strong>Mother to Child Transmission (MTCT)</strong></p>

              <p>From mothers who are HIV-positive to their infants:</p>
              <ul>
                <li>Pregnancy</li>
                <li>Labor, delivery</li>
                <li>Breastfeeding</li>
              </ul>
              
            </div>
          </section>

          <section id='heading-4-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-3'>Pathogenesis</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>Major target cells: CD4 T-lymphocytes and macrophages</li>
                <li>Binding of the viral envelope glycoprotein gp120 to the receptor as well as CCR5 or CXCR4 (Coreceptors) on the host cell CD4</li>
                <li>Fusion of the viral envelope with the cell membrane mediated by gp41, which undergoes conformational change.</li>
                <li>Viral core and its components are released into the cytoplasm</li>
                <li>Reverse transcriptase converts the single-strand viral RNA into a DNA duplex</li>
                <li>Integrase inserts (integrates) the DNA duplex into the host cell genome</li>
                <li>Once integrated into the host cell genome, the virus DNA is copied by the host cell for translation into HIV regulatory proteins</li>
                <li>Finally, HIV core containing HIV RNA, core proteins & enzymes is assembled using protease enzyme.</li>
                <li>Assembly moves to the cell surface and acquires envelope proteins by budding through the cell membrane</li>
                <li>HIV not only infects the CD4 cells, but also establishes infection in the CNS, lymphoid tissue, and testes (virus reservoirs)</li>
                <li>HIV reverse transcriptase is very error-prone, and therefore, introduces a high mutation rate in the viral genome</li>
              </ul>
              

            <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (13).png" alt="" onclick="openModal(this)">
              <div class="caption">Anatomic Compartments of HIV</div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption">Anatomic Compartments of HIV</div>
            </div>

                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (14).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>
            </div>
          </section>

          <section id='heading-4-4'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-4'>Natural Course of HIV Disease</a>
              </h3>
            </header>
            <div class='body'>
            <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (15).png" alt="" onclick="openModal(this)">
              <div class="caption">Natural Course of HIV Disease</div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption">Natural Course of HIV Disease</div>
            </div>

            <p>  Characteristic viral load and CD4 changes over time in HIV/AIDS</p>
          <p><strong>Seroconversion</strong></p>
          <ul>
            <li>Develop antibodies 4 to 6 weeks after infection</li>
            <li>May take as long as 3 months for antibodies to develop.</li>
            <li>The period of time between when a person is infected with HIV and when the antibody test result is positive is called the "window period."</li>
          </ul>

          <table class="note-table">
            <thead>
              <tr>
                <th colspan="4">CDC 1993 Revised Classification System for HIV Infection and Expanded AIDS Surveillance Case Definition for Adolescents and Adults</th>
              </tr>
              <tr>
                <th></th>
                <th colspan="3">Clinical Categories</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>CD4+ T Cell Categories</td>
                <td>A Asymptomatic, Acute (Primary) HIV or PGL</td>
                <td>B Symptomatic, Not A or C Conditions</td>
                <td>C AIDS Indicator Conditions</td>
              </tr>
              <tr>
                <td>>500/mL</td>
                <td>A1</td>
                <td>B1</td>
                <td><span style="color: red;">C1</span></td>
              </tr>
              <tr>
                <td>200-499/mL</td>
                <td>A2</td>
                <td>B2</td>
                <td><span style="color: red;">C2</span></td>
              </tr>
              <tr>
                <td> < 200/mL</td>
                <td><span style="color: red;">A3</span></td>
                <td><span style="color: red;">B3</span></td>
                <td><span style="color: red;">C3</span></td>
              </tr>
            </tbody>
          </table>
          <caption>Persons in category A3, B3, C1, C2, and C3 have AIDS under the CDC 1993 revised classification system for HIV infection and expanded AIDS surveillance case definition for adolescents and adults.</caption>
          
          
          <p><strong>AIDS-indicator conditions</strong></p>
          <p><em>Fungal Infections:</em></p>
          <ul>
            <li>Candidiasis of bronchi, trachea, and lungs</li>
            <li>Candidiasis, oesophageal</li>
            <li>Coccidioidomycosis, disseminated or extrapulmonary</li>
            <li>Cryptococcosis, extrapulmonary</li>
            <li>Histoplasmosis, disseminated or extrapulmonary</li>
          </ul>
          
          <p><em>Parasitic Infections:</em></p>
          <ul>
            <li>Cryptosporidiosis, chronic intestinal (>1 month duration)</li>
            <li>Isosporiasis, chronic intestinal (>1 month)</li>
            <li>Toxoplasmosis of brain</li>
          </ul>
          
          <p><em>Viral Infections:</em></p>
          <ul>
            <li>Cytomegalovirus disease (other than liver, spleen, or nodes)</li>
            <li>Herpes simplex: chronic ulcer(s) (>1-month duration) or bronchitis, pneumonitis, or oesophagitis</li>
            <li>Kaposi‚Äôs sarcoma</li>
            <li>Progressive multifocal leucoencephalopathy</li>
          </ul>
          
          <p><em>Bacterial Infections:</em></p>
          <ul>
            <li>Salmonella septicaemia, recurrent</li>
          </ul>
          
          <p><em>Hematological Conditions:</em></p>
          <ul>
            <li>Lymphoma, Burkitt‚Äôs (or equivalent term)</li>
            <li>Lymphoma, immunoblastic (or equivalent term)</li>
            <li>Lymphoma, primary in brain</li>
          </ul>
          
          <p><em>Pulmonary Infections:</em></p>
          <ul>
            <li>Mycobacterium avium complex or Mycobacterium kansasii, disseminated or extrapulmonary</li>
            <li>Mycobacterium tuberculosis, any site (pulmonary or extrapulmonary)</li>
            <li>Pneumocystis jiroveci pneumonia</li>
            <li>Pneumonia, recurrent</li>
          </ul>
          
          <p><em>Other Conditions:</em></p>
          <ul>
            <li>Encephalopathy, HIV-related</li>
            <li>Wasting syndrome, HIV-related</li>
            <li>Cervical cancer, invasive</li>
          </ul>
          
                      <!-- image here -->
                      <div class="image-container">
                        <img src="../figures/hiv-skin (17).png" alt="" onclick="openModal(this)">
                        <div class="caption"></div>
                      </div>
                      
                      <div id="myModal" class="modal">
                        <span class="close" onclick="closeModal()">&times;</span>
                        <img class="modal-content" id="modalImage">
                        <div id="caption" class="caption"></div>
                      </div>

                                  <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (18).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>
            

            <h4>Clinical Features of HIV Infection:</h4>
            <ul>
                <li>Acute HIV infection</li>
                <li>Primary generalized lymphadenopathy (PGL)</li>
                <li>Paediatric AIDS</li>
                <li>Central nervous system (CNS) AIDS (AIDS dementia complex)</li>
                <li>Full-blown AIDS</li>
                <li>‚ÄúAfrican presentation‚Äù</li>
            </ul>
            
            <h4>Differences in Clinical Presentation:</h4>
            <ol>
                <li>In the United States, homosexuals form the majority of patients, resulting in about a 9:1 male-to-female ratio. In Africa, the male-to-female ratio is 1:1, consistent with heterosexual transmission.</li>
                <li>Typical adult AIDS patients in the United States present with symptoms such as fever, weight loss, diarrhea, generalized lymphadenopathy, multiple opportunistic infections, neurologic disease, and, in many cases, secondary neoplasms.</li>
                <li>In African AIDS, patients often present with different symptoms, including asthenia (the most common), persistent diarrhea and fever lasting more than one month, sometimes accompanied by night sweats. These symptoms may appear together or in isolation. Some patients also develop oral candidiasis and other opportunistic infections, with the most common being cryptococcal meningitis.</li>
                <li>In America and Europe, pneumocystis jiroveci pneumonia is the most common opportunistic infection in AIDS patients. Opportunistic infections account for approximately 80% of deaths in AIDS patients.</li>
            </ol>
            
            <h4>Phases of HIV Infection:</h4>

            <ol>
                <li>
                    <strong>The Early, Acute Phase:</strong>
                    <ul>
                        <li>Represents the initial response of an immunocompetent adult to HIV infection.</li>
                        <li>Characterized by a high level of virus production, viremia, and widespread seeding of the lymphoid tissues.</li>
                        <li>Approximately 100 billion new viral particles are produced every day, and 1-2 billion CD4+ T-cells die each day.</li>
                    </ul>
                    <strong>Symptoms of Acute Phase:</strong>
                    <ul>
                        <li>Fever</li>
                        <li>Adenopathy</li>
                        <li>Pharyngitis (non-exudative)</li>
                        <li>Rash (morbilliform, maculopapular)</li>
                        <li>Diarrhea</li>
                        <li>Headache</li>
                        <li>Nausea/vomiting</li>
                        <li>Neurologic (Guillain‚ÄìBarre Syndrome, encephalitis, aseptic meningitis)</li>
                    </ul>
                </li>
                <li>
                    <strong>The Middle, Chronic Phase:</strong>
                    <ul>
                        <li>Represents a stage of relative containment of the virus.</li>
                        <li>Associated with a period of clinical latency.</li>
                        <li>Virus replication continues for several years, predominantly in the lymphoid tissues, in the setting of a largely intact immune system.</li>
                        <li>Patients are either asymptomatic or develop persistent generalized lymphadenopathy (PGL). Many patients have herpes zoster, oral thrush, or thrombocytopenia.</li>
                    </ul>
                </li>
                <li>
                    <strong>The Final, Crisis Phase:</strong>
                    <ul>
                        <li>Characterized by a breakdown of host defense, a sudden and rapid viremia, and clinical disease.</li>
                        <li>Typically, the patient presents with marked weight loss, chronic diarrhea, and fever lasting more than 1 month.</li>
                        <li>CD4 cells are generally below 200 cells/¬µl, and opportunistic infections (OIs) supervene in this stage.</li>
                        <li>The patient is said to have developed AIDS. The clinical picture will then depend on the type of OI or cancer.</li>
                    </ul>
                </li>
            </ol>
            
            <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (19).png" alt="" onclick="openModal(this)">
              <div class="caption">Opportunistic infections and malignancies in AIDS</div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption">Opportunistic infections and malignancies in AIDS</div>
            </div>

                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (3).jpg" alt="" onclick="openModal(this)">
                          <div class="caption">Tuberculous adenitis in a confirmed HIV-infected patient (with ruptured abscess on the right and suprasternal area)</div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption">Tuberculous adenitis in a confirmed HIV-infected patient (with ruptured abscess on the right and suprasternal area)</div>
                        </div>

            </div>
          </section>

          <section id='heading-4-5'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-5'>Diagnosis</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                  <li><strong>Isolation of the virus</strong></li>
                  <li><strong>Detection of viral antigen</strong></li>
                  <li><strong>Detection of viral antibody</strong></li>
              </ul>
              
              <p>Detection of viral antigen and isolation of the virus are quite expensive and technically demanding. They are therefore not widely used.</p>
              
                          <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (20).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <h4>Diagnosis of AIDS:</h4>

            <p>AIDS can be diagnosed using the WHO Clinical Case Definition in adults where diagnostic facilities are limited:</p>
            
            <p>AIDS is defined by the existence of:</p>
            
            <ul>
                <li><strong>AT LEAST 2 major signs associated with</strong></li>
                <li><strong>AT LEAST 1 minor sign in the absence of known causes of immunosuppression.</strong></li>
            </ul>
            
            <p><strong>MAJOR SIGNS:</strong></p>
            
            <ul>
                <li>Weight loss >10% body weight</li>
                <li>Chronic diarrhoea (lasting >1 month)</li>
                <li>Fever intermittent or constant (lasting >1 month)</li>
            </ul>
            
            <p><strong>MINOR SIGNS:</strong></p>
            
            <ul>
                <li>Persistent cough (>1 month)</li>
                <li>Generalized pruritic dermatitis</li>
                <li>Recurrent herpes zoster</li>
                <li>Oropharyngeal candidiasis</li>
                <li>Chronic progressive and disseminated herpes virus infection</li>
                <li>Generalized lymphadenopathy</li>
            </ul>
            
            </div>
          </section>

          <section id='heading-4-6'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-6'>Investigations</a>
              </h3>
            </header>
            <div class='body'>
              <p>Initial Investigations should include:</p>
              
              <ul>
                  <li>Complete blood count (haemoglobin [Hb], haematocrit [Hct], white blood count [WBC] with differentials, platelets, MCV).</li>
                  <li>Liver function tests (alkaline phosphatase, alanine transferase [ALT], aspartate transaminase [AST], gamma glutamyl transpeptidase [GGT], lactate dehydrogenase [LDH], protein/albumin.</li>
                  <li>Other routine baseline investigations not related to HIV (e.g., fasting blood glucose, cholesterol [total], triglycerides, high-density lipoprotein, low-density lipoprotein, blood urea nitrogen [BUN], and creatinine).</li>
                  <li>HBsAg</li>
                  <li>anti-HBs</li>
                  <li>anti-HCV</li>
                  <li>VDRL (and confirmatory test, as it may be difficult to diagnose syphilis in HIV-positive patients).</li>
                  <li>Toxoplasmosis, cytomegalovirus, cryptococcal antigen, Epstein-Barr virus - not useful as routine screening tests.</li>
                  <li>Pulmonary function tests and chest radiography as a baseline may be helpful.</li>
                  <li>Tuberculin skin test. If negative, repeat in two weeks and do anergy screen if CD4 count is less than 200/mm3.</li>
                  <li>CD4 counts</li>
                  <li>Pap smear and swabs for culture and sensitivity and yeast in women.</li>
                  <li>Viral load</li>
              </ul>
              
              <p><strong>NB. Other relevant investigations may be indicated depending on the presenting features and possible aetiology.</strong></p>
              
            </div>
          </section>

          <section id='heading-4-7'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-7'>Treatment</a>
              </h3>
            </header>
            <div class='body'>
              <h4>Treatment Goals:</h4>

              <p><strong>Clinical:</strong></p>
              <ul>
                  <li>Prolong survival</li>
                  <li>Prevent disease progression</li>
                  <li>Minimize toxicity</li>
              </ul>
              
              <p><strong>Virological:</strong></p>
              <ul>
                  <li>Maximal and durable suppression of viral load for as long as possible to below detectable levels (currently defined as &lt;50 copies/ml)</li>
              </ul>
              
              <p><strong>Immunological:</strong></p>
              <ul>
                  <li>Preserve immune function (CD4 cell count in normal range)</li>
              </ul>
              
              <p><strong>Public health:</strong></p>
              <ul>
                  <li>Reduce HIV transmission</li>
                  <li>Preserve future treatment options</li>
              </ul>
              

              <h4>Management:</h4>

              <p>Caring for people with HIV infection is extremely difficult for a number of reasons:</p>
              
              <ol type="a">
                  <li> HIV infection is incurable.</li>
                  <li> Infected individuals need to be counseled to ensure they do not transmit the disease to others.</li>
                  <li) The infection is associated with stigmatization and discrimination.</li>
                  <li> Diagnosing HIV-related diseases may be problematic, as they often present with atypical clinical manifestations and may occur simultaneously, even in the same organs.</li>
                  <li> Unavailability of treatment for some HIV-related diseases.</li>
                  <li> Patients often develop serious adverse effects to drugs.</li>
                  <li> The number of healthcare workers with experience in counseling and managing people with HIV is limited, particularly in Africa.</li>
              </ol>

                          <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (21).png" alt="" onclick="openModal(this)">
              <div class="caption">Antiretroviral Agents</div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption">Antiretroviral Agents</div>
            </div>
              

            <h4>CRITICAL QUESTIONS IN HAART:</h4>

            <ul>
                <li>When to initiate therapy?</li>
                <li>What is the optimal initial therapy?</li>
                <li>When to change therapy?</li>
                <li>What are the optimal subsequent therapies?</li>
            </ul>
            
            <h4>WHEN TO INITIATE HAART?</h4>
            
            <p>The initiation of Highly Active Antiretroviral Therapy (HAART) depends on several factors:</p>
            
            <ol>
                <li>The presence of an AIDS-defining illness irrespective of HIV RNA level or CD4+ cell count.</li>
                <li>All patients with CD4+ cell count &lt;200/mL irrespective of HIV RNA level.</li>
                <li>All patients with CD4+ cell count between 200-350/mL (especially if HIV RNA level &gt;20,000 copies/mL).</li>
                <li>Most patients with CD4+ cell count &gt;350/mL only if HIV RNA level &gt;55,000 copies/mL.</li>
            </ol>
            
            <p>WHO recommends that in ARV treatment programs in resource-limited settings HIV-infected adolescents and adults should start ARV therapy when they have:</p>
            
            <ul>
                <li>WHO stage IV of HIV disease (clinical AIDS), regardless of CD4 count.</li>
                <li>WHO stages I, II, or III of HIV disease, with a CD4 count below 200/mm3.</li>
                <li>WHO stages II or III of HIV disease with TLC below 1200/mm3.</li>
            </ul>
            

            <h4>Special Considerations for ARVs:</h4>

            <ol>
                <li>Pregnancy: Efavirenz is contraindicated in pregnancy because it has been found to be teratogenic in animals and associated with myelomeningoceles in humans.</li>
                <li>HIV-associated tuberculosis: Because of the interactions between NNRTIs, particularly nevirapine, PIs and rifampin.</li>
            </ol>
            
            <h4>Risks and Benefits of Early Therapy:</h4>
            
            <p>When considering early therapy for HIV, it's essential to weigh the potential risks and benefits:</p>
            
            <h5>Benefits of early therapy:</h5>
            
            <ul>
                <li>Control of viral replication is easier.</li>
                <li>Prevention of immune system compromise.</li>
                <li>Lower risk of resistance with complete viral suppression.</li>
                <li>Possible decreased risk of HIV transmission.</li>
            </ul>
            
            <h5>Risks of early therapy:</h5>
            
            <ul>
                <li>Drug-related reduction in quality of life.</li>
                <li>Greater cumulative drug-related adverse events.</li>
                <li>Earlier development of drug resistance.</li>
                <li>Limitation of future antiretroviral Rx options.</li>
            </ul>


                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (22).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>

                                    <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (23).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>
            

            <h4>Special Considerations for ARVs:</h4>

            <ol>
                <li>Pregnancy: Efavirenz is contraindicated in pregnancy because it has been found to be teratogenic in animals and associated with myelomeningoceles in humans.</li>
                <li>HIV-associated tuberculosis: Because of the interactions between NNRTIs, particularly nevirapine, PIs and rifampin.</li>
            </ol>
            
            <h4>Risks and Benefits of Early Therapy:</h4>
            
            <p>When considering early therapy for HIV, it's essential to weigh the potential risks and benefits:</p>
            
            <h5>Benefits of early therapy:</h5>
            
            <ul>
                <li>Control of viral replication is easier.</li>
                <li>Prevention of immune system compromise.</li>
                <li>Lower risk of resistance with complete viral suppression.</li>
                <li>Possible decreased risk of HIV transmission.</li>
            </ul>
            
            <h5>Risks of early therapy:</h5>
            
            <ul>
                <li>Drug-related reduction in quality of life.</li>
                <li>Greater cumulative drug-related adverse events.</li>
                <li>Earlier development of drug resistance.</li>
                <li>Limitation of future antiretroviral Rx options.</li>
            </ul>
            

            <h4>Monitoring of HAART:</h4>

            <p>When on Highly Active Antiretroviral Therapy (HAART), monitoring involves the following:</p>
            
            <ul>
                <li>Measure plasma HIV RNA levels at various intervals:</li>
                <ul>
                    <li>Immediately prior to initiation of Rx</li>
                    <li>At 2-8 weeks after Rx</li>
                    <li>3-4 months after the start of therapy</li>
                    <li>Repeat every 3-4 months while being on therapy</li>
                    <li>In case of a clinical event or a significant decline in CD4+ T cells</li>
                </ul>
                <li>CD4+ T cell counts at the time of diagnosis and generally every 3-6 months thereafter</li>
            </ul>
            
            <h4>Changing Regimens/Switching Drugs:</h4>
            
            <p>During the course of therapy, there are several reasons to consider changing regimens:</p>
            
            <ol>
                <li>Toxicity:</li>
                <ul>
                    <li>Adverse reactions to a particular ARV drug in the regimen.</li>
                    <li>Change only the offending drug, retaining accompanying ARV drugs.</li>
                </ul>
                <li>Inconvenience of regimen</li>
                <li>Pregnancy</li>
                <li>TB treatment</li>
                <li>Therapy Failure:</li>
                <ul>
                    <li>Inability of the drug regimen to suppress the replication of the HIV virus.</li>
                    <li>Change the entire regimen.</li>
                </ul>
            </ol>
            

            <h4>Definition of Therapy Failure:</h4>

            <p>Therapy failure in the context of HIV treatment can be defined based on clinical, immunological, and virological criteria:</p>
            
            <p><strong>Clinical:</strong></p>
            
            <ul>
                <li>Onset of new or recurrence of opportunistic infections</li>
                <li>Onset or recurrence of WHO stage III-defining condition</li>
            </ul>
            
            <p><em>Note: Consider Immune Reconstitution Inflammatory Syndrome (IRIS).</em></p>
            
            <p><strong>Immunological:</strong></p>
            
            <ul>
                <li>Return of CD4 count to pretherapy level</li>
                <li>30% fall in CD4 count from peak level during therapy</li>
                <li>Failure to achieve a CD4 cell count increase of 50-100 cells per year</li>
            </ul>
            
            <p><strong>Virological:</strong></p>
            
            <ul>
                <li>Viral load not suppressed to undetectable levels after 4-6 months of ART</li>
                <li>A persistent increase in viral load following a period of adequate suppression</li>
            </ul>

                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (24).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>
            
                        <h4>CROSS-RESISTANCE- Considerations for Changing Antiretroviral Regimens:</h4>

                        <ul>
                            <li>Avoid changing among NNRTIs because viral strains that become resistant to one NNRTI have reduced susceptibility to other NNRTIs.</li>
                            <li>Cross-resistance is also seen among PIs, such as Ritonavir and Indinavir.</li>
                            <li>In general, cross-resistance is not a major concern with NRTIs (Nucleoside Reverse Transcriptase Inhibitors).</li>
                            <li>Use of drug resistance testing in this setting is helpful.</li>
                        </ul>
                        
            </div>
          </section>

          <section id='heading-4-8'>
            <header>
              <h3>
                <a aria-hidden href='#heading-4-8'>Prevention and Control of HIV/AIDS</a>
              </h3>
            </header>
            <div class='body'>
              <p>The absence of a curative treatment or vaccine makes prevention of HIV transmission essential to controlling the epidemic.</p>
              
              <ul>
                  <li>General public education about HIV to prevent its spread.</li>
                  <li>Patients at risk should be targeted for specific education and risk reduction. Different outlets for information dissemination such as clinics, radio, television, traditional institutions, and public fora should be used.</li>
                  <li>Active collaboration between organs of society including the healthcare sector, political class, general population, and faith-based organizations.</li>
                  <li>Within the healthcare sector, clinicians require ongoing collaboration with social workers, health education specialists, mental health specialists, and patients.</li>
                  <li>In all settings, especially those that are resource-poor, selection of the most cost-effective interventions is imperative because allocation of resources to one intervention may prevent implementation of other interventions.</li>
                  <li>Address squarely the issue of sexual promiscuity or excessive sexual activity.</li>
                  <li>Restrict themselves to one partner only, if married.</li>
                  <li>If unmarried, they should abstain or restrict themselves to the person they know best.</li>
                  <li>At worst, condom use should be emphasized to those who cannot abstain.</li>
                  <li>People must not shy away from screening themselves periodically if they expose themselves to more than one partner.</li>
                  <li>Provide early diagnosis and treatment of STIs.</li>
                  <li>Make HIV testing and counseling widely available.</li>
                  <li>Provide suitable counseling for women who are HIV-negative.</li>
                  <li>Prevention of unintended pregnancies among HIV-positive women.</li>
                  <li>Testing and counseling of pregnant women.</li>
                  <li>ARV Prophylaxis for mother-child pairs.</li>
                  <li>Modification of infant feeding practices and support.</li>
                  <li>Safe blood transfusion practices (transfuse only HIV-negative blood).</li>
                  <li>Use sterile materials like needles, blades, and instruments.</li>
              </ul>
              
            </div>
          </section>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Summary/Conclusion</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li>Adherence</li>
              <li>Be Knowledgeable</li>
              <li>Community</li>
              <li>Do not squander scarce resources</li>
          </ul>
          
          <h4>What is HIV?</h4>
          
          <p>Human Immunodeficiency Virus (HIV) is a retrovirus infection that causes acquired immunodeficiency of the host by reducing the number of CD4 T cells.</p>
          <p>Without appropriate treatment, a person with HIV will eventually progress to the advanced stage of infection, Acquired Immunodeficiency Syndrome (AIDS).</p>
          
          <h4>Who gets skin disease in HIV?</h4>
          
          <p>Dermatological conditions are extremely common during HIV infection and will affect approximately 90% of all people living with HIV. These conditions can be both specific to HIV, as well as common skin problems found in the general population.</p>
          <p>The acquired immunodeficiency associated with HIV puts patients at increased risk of many skin conditions, including malignancy and infection.</p>
          <p>Antiretroviral medications themselves can also be implicated, with many having high reaction rates and increased photosensitivity risk.</p>
          
          <h4>What types of skin disease are found in HIV?</h4>
          
          <p><strong>Infections:</strong></p>
          <p>Increased susceptibility to bacterial, viral, fungal, and parasitic infections is common, and these can appear at different stages of the disease.</p>
          
          <p><strong>Bacterial:</strong></p>
          <p>Streptococcal and staphylococcal skin infections may be more severe than in the general population, and there is a stronger association with MRSA infection. These infections include:</p>
          <ul>
              <li>Cellulitis</li>
              <li>Ecthyma</li>
              <li>Impetigo</li>
              <li>Folliculitis</li>
          </ul>
          

                      <!-- image here -->
                      <div class="image-container">
                        <img src="../figures/hiv-skin (25).png" alt="" onclick="openModal(this)">
                        <div class="caption"></div>
                      </div>
                      
                      <div id="myModal" class="modal">
                        <span class="close" onclick="closeModal()">&times;</span>
                        <img class="modal-content" id="modalImage">
                        <div id="caption" class="caption"></div>
                      </div>

                                  <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (26).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <h4>Viral:</h4>

            <p>During the acute HIV infection syndrome (in the first few weeks after initial exposure), patients can develop a symmetrical maculopapular erythematous exanthem that involves the face, palms, soles, trunk, and limbs, in conjunction with systemic viral symptoms. There may also be mucocutaneous ulceration.</p>
            
                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (27).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>

                                    <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (4).jpg" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <h4>Fungal:</h4>

            <p>There are a range of fungal infections that occur at different degrees of immunocompromise in HIV. Common presentations such as tinea (of any body area) and onychomycosis and candidal infections can occur early, but are more likely to be severe, atypical in nature, and less responsive to treatment.</p>
            
            <p>Pityrosporum folliculitis and pityriasis versicolor are both conditions caused by Malassezia yeasts, commonly found as part of the normal skin microflora. The former produces an acne-like inflammation around the hair follicle, whereas the latter causes hyper or hypo-pigmented lesions over the skin.</p>
            
            <p>Systemic mycoses constitute a group of both endemic and opportunistic fungal infections, and cutaneous involvement can be an indicator of disseminated infection. The dermatological features of these diseases vary greatly between patients and organisms, and typically rely on skin biopsy and blood cultures for diagnosis.</p>
            
            <p>HIV-associated systemic mycoses include:</p>
            <ul>
              <li>Cryptococcosis</li>
              <li>Blastomycosis</li>
              <li>Histoplasmosis</li>
              <li>Talaromycosis</li>
              <li>Aspergillosis</li>
              <li>Pneumocystosis</li>
            </ul>
            

                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (28).png" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>

                                    <!-- image here -->
            <div class="image-container">
              <img src="../figures/hiv-skin (29).png" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <h4>Inflammatory:</h4>

            <p>Psoriasis, seborrheic dermatitis, and eczema are common dermatological conditions in the general population. In people living with HIV, they are often more severe, treatment resistant, and likely to become secondarily infected.</p>
            
            <p>Psoriasis in HIV infection is more likely to present with atypical morphology which can cause diagnostic difficulty. It can worsen acutely and progress to erythroderma with declining immune function.</p>

                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/hiv-skin (5).jpg" alt="" onclick="openModal(this)">
                          <div class="caption"></div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption"></div>
                        </div>
            
                        <h4>Outcome for Skin Conditions in HIV:</h4>

                        <p>With increased availability of HAART, life expectancy for people with HIV is rising steadily. The prognosis for skin conditions associated with low CD4 counts is therefore improving as many will be resistant to optimal treatment without improved underlying immune function.</p>
                        
                        <p>Without commencing HAART, people with HIV will ultimately progress to the development of AIDS and its associated complications. Malignancy and disseminated opportunistic infections carry high mortality rates.</p>
                
        </div>
      </section>


      </section>

      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
